COPD Inhaled Medications
|Personalized education in 30-60 minutes in your office at a time that is convenient for you. This Group Learning program has been certified by the College of Family Physicians of Canada for up to 2.0 Mainpro+ credits.|
Participants will be able to apply evidence about inhaled medications and devices to confidently initiate, re-evaluate
and discontinue medications for their COPD patients.
During the academic detailing session, participants will have the opportunity to:
- Discuss the effect of intensifying inhaled therapies on health-related quality of life, the risk of exacerbations
and the risk of death (i.e., when progressing to double or triple therapy);
- Discuss relevant clinical considerations when prescribing and monitoring patients receiving inhaled therapies;
- Compare efficacy, safety, dosing and costs of inhaled therapies; and
- Describe the advantages and disadvantages of various medication inhalation devices.
When: Until September 14, 2018
Where: Your office at your convenience, or via individual Web session
How: Email email@example.com or Phone 604 660-0382
For more information about the PAD service, visit PAD Frequently Asked Questions.